Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Parkinson's Disease

Free Subscription Articles published in Nat Med Retrieve available abstracts of 23 articles: HTML format

Single Articles

September 2025
1. ALI M, Erabadda B, Chen Y, Xu Y, et al
   Author Correction: Shared and disease-specific pathways in frontotemporal dementia and Alzheimer's and Parkinson's diseases.
   Nat Med. 2025 Sep 2. doi: 10.1038/s41591-025-03970.
   PubMed    
   
   
   August 2025
2. SHVETCOV A, Johnson ECB, Winchester LM, Walker KA, et al
   APOE epsilon4 carriers share immune-related proteomic changes across neurodegenerative diseases.
   Nat Med. 2025;31:2590-2601.
   PubMed     Abstract available
   
   
   
3. IMAM F, Saloner R, Vogel JW, Krish V, et al
   The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging.
   Nat Med. 2025;31:2556-2566.
   PubMed     Abstract available
   
   
   July 2025
4. ALI M, Erabadda B, Chen Y, Xu Y, et al
   Shared and disease-specific pathways in frontotemporal dementia and Alzheimer's and Parkinson's diseases.
   Nat Med. 2025 Jul 15. doi: 10.1038/s41591-025-03833.
   PubMed     Abstract available
   
   
   June 2025
5. HEALEY N
   Stem cell therapies advance in Parkinson's disease and beyond.
   Nat Med. 2025 Jun 4. doi: 10.1038/d41591-025-00036.
   PubMed    
   
   
   April 2025
6. O'LEARY K
   Progress with stem cell therapy in Parkinson's disease.
   Nat Med. 2025 Apr 30. doi: 10.1038/d41591-025-00029.
   PubMed    
   
   
   February 2025
7. SOTO C, Mollenhauer B, Hansson O, Kang UJ, et al
   Toward a biological definition of neuronal and glial synucleinopathies.
   Nat Med. 2025;31:396-408.
   PubMed     Abstract available
   
   
   January 2025
8. MOREAU C, Odou P, Labreuche J, Demailly A, et al
   Intracerebroventricular anaerobic dopamine in Parkinson's disease with L-dopa-related complications: a phase 1/2 randomized-controlled trial.
   Nat Med. 2025 Jan 7. doi: 10.1038/s41591-024-03428.
   PubMed     Abstract available
   
   
   
9. CASTRO-ALDRETE L, Huc M, Domingos J, Vaudano E, et al
   Using a sex- and gender-informed lens to enhance care in Parkinson's disease.
   Nat Med. 2025 Jan 3. doi: 10.1038/s41591-024-03363.
   PubMed    
   
   
   October 2024
10. PAGANO G, Monnet A, Reyes A, Ribba B, et al
    Sustained effect of prasinezumab on Parkinson's disease motor progression in the open-label extension of the PASADENA trial.
    Nat Med. 2024 Oct 8. doi: 10.1038/s41591-024-03270.
    PubMed     Abstract available
    
    
    September 2024
11. EIJSVOGEL P, Misra P, Concha-Marambio L, Boyd JD, et al
    Target engagement and immunogenicity of an active immunotherapeutic targeting pathological alpha-synuclein: a phase 1 placebo-controlled trial.
    Nat Med. 2024;30:2631-2640.
    PubMed     Abstract available
    
    
    August 2024
12. OEHRN CR, Cernera S, Hammer LH, Shcherbakova M, et al
    Chronic adaptive deep brain stimulation versus conventional stimulation in Parkinson's disease: a blinded randomized feasibility trial.
    Nat Med. 2024 Aug 19. doi: 10.1038/s41591-024-03196.
    PubMed     Abstract available
    
    
    April 2024
13. MULIYIL S
    Repurposing a diabetes drug to treat Parkinson's disease.
    Nat Med. 2024 Apr 20. doi: 10.1038/d41591-024-00026.
    PubMed    
    
    
    
14. PAGANO G, Taylor KI, Anzures Cabrera J, Simuni T, et al
    Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson's disease.
    Nat Med. 2024;30:1096-1103.
    PubMed     Abstract available
    
    
    January 2024
15. 
    Wearable robot helps man with Parkinson's disease to walk.
    Nat Med. 2024 Jan 15. doi: 10.1038/s41591-023-02756.
    PubMed    
    
    
    
16. KIM J, Porciuncula F, Yang HD, Wendel N, et al
    Soft robotic apparel to avert freezing of gait in Parkinson's disease.
    Nat Med. 2024 Jan 5. doi: 10.1038/s41591-023-02731.
    PubMed     Abstract available
    
    
    November 2023
17. MIZRAHI-KLIGER A, Ganguly K
    Spinal stimulation for unfreezing gait in Parkinson's disease.
    Nat Med. 2023 Nov 6. doi: 10.1038/s41591-023-02604.
    PubMed    
    
    
    
18. MILEKOVIC T, Moraud EM, Macellari N, Moerman C, et al
    A spinal cord neuroprosthesis for locomotor deficits due to Parkinson's disease.
    Nat Med. 2023 Nov 6. doi: 10.1038/s41591-023-02584.
    PubMed     Abstract available
    
    
    August 2023
19. QUADALTI C, Palmqvist S, Hall S, Rossi M, et al
    Clinical effects of Lewy body pathology in cognitively impaired individuals.
    Nat Med. 2023;29:1964-1970.
    PubMed     Abstract available
    
    
    July 2023
20. SCHALKAMP AK, Peall KJ, Harrison NA, Sandor C, et al
    Wearable movement-tracking data identify Parkinson's disease years before clinical diagnosis.
    Nat Med. 2023 Jul 3. doi: 10.1038/s41591-023-02440.
    PubMed     Abstract available
    
    
    June 2023
21. OKUZUMI A, Hatano T, Matsumoto G, Nojiri S, et al
    Propagative alpha-synuclein seeds as serum biomarkers for synucleinopathies.
    Nat Med. 2023;29:1448-1455.
    PubMed     Abstract available
    
    
    April 2023
22. O'LEARY K
    Biomarker study a game-changer for Parkinson's disease.
    Nat Med. 2023 Apr 27. doi: 10.1038/d41591-023-00039.
    PubMed    
    
    
    March 2023
23. O'LEARY K
    Ultrasound-based treatment for Parkinson's disease.
    Nat Med. 2023 Mar 6. doi: 10.1038/d41591-023-00026.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.